Signaturefd, LLC Provention Bio, Inc. Transaction History

Signaturefd, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 27, 2023	BUY	$4.52 - $10.57 $302 - $708	67 New	67 $0
Q2 2022 Aug 10, 2022	SELL	$3.65 - $7.3 $237 - $474	-65 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$3.4 - $7.88 $119 - $275	-35 Reduced 35.0%	65 $0
Q4 2021 Jan 25, 2022	SELL	$5.59 - $7.39 $240 - $317	-43 Reduced 30.07%	100 $1,000
Q3 2021 Oct 28, 2021	BUY	$5.66 - $8.33 $809 - $1,191	143 New	143 $1,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.